Long-term danazol administration

International Journal of Gynecology and Obstetrics

Volumn 53, Issue 1, 1996, Pages 61-62

  Chuong, C J ^a,b   Monsalve, J A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Danazol; Endometriosis

Indexed keywords

CALCIUM; DANAZOL; ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ABDOMINAL PAIN; ACNE; ADULT; ARTHRITIS; ARTICLE; ASTHMA; BREAST DISEASE; BRUXISM; CARPAL TUNNEL SYNDROME; CASE REPORT; DEPRESSION; DRUG ERUPTION; EDEMA; ENDOMETRIOSIS; EPISTAXIS; FEMALE; HAIR LOSS; HEART ARRHYTHMIA; HIP DISEASE; HIRSUTISM; HOARSENESS; HUMAN; HYPOGLYCEMIA; LOW BACK PAIN; MICTURITION DISORDER; MYALGIA; NAIL DISEASE; NAUSEA; ORAL DRUG ADMINISTRATION; PARESTHESIA; PRIORITY JOURNAL; SPEECH DISORDER; TRANSDERMAL DRUG ADMINISTRATION; VAGINA ATROPHY; VAGINA BLEEDING; VISUAL DISORDER; WEIGHT GAIN;

EID: 0029921034     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(96)80013-0     Document Type: Letter

References (2)

1. Zurlo JJ, Frank MM. The long-term safety of danazol in women with hereditary angioedema. Fertil Steril 1990; 54: 64-72.
2. Buttram VC Jr, Reiter RC, Ward S. Treatment of endometriosis with danazol: report of a 6-year prospective study. Fertil Steril 1985; 43: 353-360.